{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:43:57Z","timestamp":1793519037076,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":763,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["17\u201000\u201000141 (17\u201000\u201000140)"],"award-info":[{"award-number":["17\u201000\u201000141 (17\u201000\u201000140)"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["17\u201004\u201001309"],"award-info":[{"award-number":["17\u201004\u201001309"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["18\u201034\u20102"],"award-info":[{"award-number":["18\u201034\u20102"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1111\/jth.14943","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T13:27:31Z","timestamp":1591622851000},"page":"2672-2684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib"],"prefix":"10.1016","volume":"18","author":[{"given":"Elena A.","family":"Dmitrieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene A.","family":"Nikitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Ignatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir I.","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr V.","family":"Poletaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7534-3863","authenticated-orcid":false,"given":"Elena A.","family":"Seregina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill A.","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-2878","authenticated-orcid":false,"given":"Dmitry M.","family":"Polokhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey A.","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina A.","family":"Novichkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Panteleev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim V.","family":"Ptushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14943_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40265-017-0695-3","article-title":"Ibrutinib: a review in chronic lymphocytic leukaemia","volume":"77","author":"Deeks","year":"2017","journal-title":"Drugs"},{"key":"10.1111\/jth.14943_bb0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bjh.15690","article-title":"Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: an integrated analysis","volume":"184","author":"Brown","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14943_bb0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clml.2018.07.287","article-title":"Risk of major bleeding with Ibrutinib","volume":"18","author":"Mock","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1111\/jth.14943_bb0025","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2015.126672","article-title":"Incidence and risk factors of bleeding\u2010related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib","volume":"100","author":"Lipsky","year":"2015","journal-title":"Haematologica"},{"key":"10.1111\/jth.14943_bb0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/leu.2014.247","article-title":"Ibrutinib inhibits collagen\u2010mediated but not ADP\u2010mediated platelet aggregation","volume":"29","author":"Kamel","year":"2015","journal-title":"Leukemia"},{"key":"10.1111\/jth.14943_bb0035","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2014-06-583294","article-title":"Ibrutinib treatment affects collagen and von Willebrand factor\u2010dependent platelet functions","volume":"124","author":"Levade","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.14943_bb0040","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/ATVBAHA.115.306130","article-title":"Ibrutinib inhibits platelet integrin alphaIIbbeta3 outside\u2010in signaling and thrombus stability but not adhesion to collagen","volume":"35","author":"Bye","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14943_bb0045","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2006-01-011817","article-title":"Bruton tyrosine kinase is essential for botrocetin\/VWF\u2010induced signaling and GPIb\u2010dependent thrombus formation in vivo","volume":"108","author":"Liu","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.14943_bb0050","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/bloodadvances.2017011999","article-title":"Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib","volume":"1","author":"Bye","year":"2017","journal-title":"Blood Adv"},{"key":"10.1111\/jth.14943_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.119.262063","article-title":"Relative selectivity of covalent inhibitors requires assessment of inactivation kinetics and cellular occupancy: a case study of Ibrutinib and Acalabrutinib","volume":"372","author":"Hopper","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jth.14943_bb0060","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2147\/CMAR.S219570","article-title":"Acalabrutinib and its therapeutic potential in the treatment of chronic lymphocytic leukemia: a short review on emerging data","volume":"12","author":"Isaac","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1111\/jth.14943_bb0065","first-page":"49","article-title":"Platelet function in chronic leukemias","volume":"29","author":"Naresh","year":"1992","journal-title":"Indian J Cancer"},{"key":"10.1111\/jth.14943_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-5-23","article-title":"CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia","volume":"5","author":"Pulte","year":"2007","journal-title":"J Transl Med"},{"key":"10.1111\/jth.14943_bb0075","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/cam4.2134","article-title":"Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre\u2010ibrutinib era: Incidence and risk factors","volume":"8","author":"Georgantopoulos","year":"2019","journal-title":"Cancer Med"},{"key":"10.1111\/jth.14943_bb0080","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/leu.2016.316","article-title":"Ristocetin\u2010induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib","volume":"31","author":"Kazianka","year":"2017","journal-title":"Leukemia"},{"issue":"12","key":"10.1111\/jth.14943_bb0085","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2013Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.14943_bb0090","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1111\/jth.14943_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj3060337","article-title":"Integrin alpha 2 beta 1\u2010independent activation of platelets by simple collagen\u2010like peptides: collagen tertiary (triple\u2010helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1\u2010independent platelet reactivity","volume":"306","author":"Morton","year":"1995","journal-title":"Biochem J"},{"key":"10.1111\/jth.14943_bb0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.thromres.2018.08.024","article-title":"Alterations in the parameters of classic, global, and innovative assays of hemostasis caused by sample transportation via pneumatic tube system","volume":"170","author":"Poletaev","year":"2018","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14943_bb0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/vox.12364","article-title":"Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution","volume":"110","author":"Ignatova","year":"2016","journal-title":"Vox Sang"},{"issue":"4","key":"10.1111\/jth.14943_bb0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/09537104.2018.1513473","article-title":"Flow cytometry for pediatric platelets","volume":"30","author":"Ignatova","year":"2019","journal-title":"Platelets"},{"key":"10.1111\/jth.14943_bb0115","doi-asserted-by":"crossref","first-page":"C373","DOI":"10.1152\/ajpcell.00325.2015","article-title":"Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI\u2010mediated platelet function","volume":"310","author":"Rigg","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/jth.14943_bb0120","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3324\/haematol.2018.207183","article-title":"Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions","volume":"104","author":"Series","year":"2019","journal-title":"Haematologica"},{"key":"10.1111\/jth.14943_bb0125","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI115485","article-title":"Inhibition of platelet function by an aspirin\u2010insensitive endothelial cell ADPase. thromboregulation by endothelial cells","volume":"88","author":"Marcus","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14943_bb0130","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.3324\/haematol.2016.155978","article-title":"Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis","volume":"102","author":"Lee","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1111\/jth.14943_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2019.04.001","article-title":"Platelet counts and risk of major bleeding with Ibrutinib","volume":"19","author":"Lucijanic","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1111\/jth.14943_bb0140","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1182\/blood-2016-12-737346","article-title":"Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL\/SLL","volume":"129","author":"Barr","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.14943_bb0145","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2012-12-467415","article-title":"Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT\u2010263)","volume":"121","author":"Qiao","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14943","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14943","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14943","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622011540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622011540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:27:51Z","timestamp":1761535671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622011540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1538783622011540"],"URL":"https:\/\/doi.org\/10.1111\/jth.14943","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}